{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:21:36Z","timestamp":1782944496234,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,31]],"date-time":"2017-07-31T00:00:00Z","timestamp":1501459200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["heliyon.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.heliyon.2018.e00508","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T02:23:27Z","timestamp":1516242207000},"page":"e00508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington\u2019s disease mice"],"prefix":"10.1016","volume":"4","author":[{"given":"Kathleen","family":"Griffioen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Mattson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitan","family":"Okun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.heliyon.2018.e00508_bib0005","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1468-1331.2010.02973.x","article-title":"Autonomic symptoms in patients and pre-manifest mutation carriers of Huntington's disease","volume":"17","author":"Aziz","year":"2010","journal-title":"Eur. J. Neurol."},{"issue":"3","key":"10.1016\/j.heliyon.2018.e00508_bib0010","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.ncl.2009.04.001","article-title":"Huntington disease and other choreas","volume":"27","author":"Cardoso","year":"2009","journal-title":"Neurol. Clin."},{"issue":"8","key":"10.1016\/j.heliyon.2018.e00508_bib0015","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1084\/jem.20080178","article-title":"A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease","volume":"205","author":"Bjorkqvist","year":"2008","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.heliyon.2018.e00508_bib0020","doi-asserted-by":"crossref","first-page":"541259","DOI":"10.1155\/2013\/541259","article-title":"The role of the immune system in Huntington's disease","volume":"2013","author":"Ellrichmann","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"12","key":"10.1016\/j.heliyon.2018.e00508_bib0025","doi-asserted-by":"crossref","first-page":"e0143563","DOI":"10.1371\/journal.pone.0143563","article-title":"RNA sequence analysis of human Huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression","volume":"10","author":"Labadorf","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.heliyon.2018.e00508_bib0030","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1097\/WNR.0b013e32832e34ee","article-title":"Distinct neuroinflammatory profile in post-mortem human Huntington's disease","volume":"20","author":"Silvestroni","year":"2009","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/j.heliyon.2018.e00508_bib0035","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2015.04.007","article-title":"The choreography of neuroinflammation in Huntington's disease","volume":"36","author":"Crotti","year":"2015","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.heliyon.2018.e00508_bib0040","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0092-8674(00)81369-0","article-title":"Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice","volume":"87","author":"Mangiarini","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.heliyon.2018.e00508_bib0045","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbi.2014.09.011","article-title":"Plasma inflammatory biomarkers for Huntington's disease patients and mouse model","volume":"44","author":"Chang","year":"2015","journal-title":"Brain Behav. Immunol."},{"issue":"16","key":"10.1016\/j.heliyon.2018.e00508_bib0050","doi-asserted-by":"crossref","first-page":"4328","DOI":"10.1093\/hmg\/ddu151","article-title":"Inhibition of soluble tumor necrosis factor is therapeutic in Huntington's disease","volume":"23","author":"Hsiao","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"7","key":"10.1016\/j.heliyon.2018.e00508_bib0055","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1021\/pr0700753","article-title":"Proteomic profiling of plasma in Huntington's disease reveals neuroinflammatory activation and biomarker candidates","volume":"6","author":"Dalrymple","year":"2007","journal-title":"J. Proteome Res."},{"issue":"11","key":"10.1016\/j.heliyon.2018.e00508_bib0060","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2007.09.002","article-title":"Signaling to NF-kappaB by Toll-like receptors","volume":"13","author":"Kawai","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"7\u20138","key":"10.1016\/j.heliyon.2018.e00508_bib0065","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2119\/2008-00034.Klune","article-title":"HMGB1: endogenous danger signaling","volume":"14","author":"Klune","year":"2008","journal-title":"Mol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2018.e00508_bib0070","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.smim.2003.10.003","article-title":"TLR signaling pathways","volume":"16","author":"Takeda","year":"2004","journal-title":"Semin. Immunol."},{"issue":"9","key":"10.1016\/j.heliyon.2018.e00508_bib0075","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/mp.2011.28","article-title":"The role of immunity in Huntington's disease","volume":"16","author":"Soulet","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.heliyon.2018.e00508_bib0080","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.12688\/f1000research.12036.1","article-title":"CNS cell-type localization and LPS response of TLR signaling pathways","volume":"6","author":"McCarthy","year":"2017","journal-title":"F1000 Res."},{"issue":"13","key":"10.1016\/j.heliyon.2018.e00508_bib0085","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA is an endogenous ligand for Toll-like receptor 3","volume":"279","author":"Kariko","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.heliyon.2018.e00508_bib0090","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.4049\/jimmunol.0902419","article-title":"The microtubule regulator stathmin is an endogenous protein agonist for TLR3","volume":"184","author":"Bsibsi","year":"2010","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.heliyon.2018.e00508_bib0095","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/00001756-200006050-00032","article-title":"LPS-induced neuroinflammatory effects do not recover with time","volume":"11","author":"Hauss-Wegrzyniak","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.heliyon.2018.e00508_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-2094-3-21","article-title":"Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity","volume":"3","author":"Maezawa","year":"2006","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.heliyon.2018.e00508_bib0105","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.0105-2896.2005.00239.x","article-title":"Toll-like receptors, endogenous ligands, and systemic autoimmune disease","volume":"204","author":"Rifkin","year":"2005","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.heliyon.2018.e00508_bib0110","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.4049\/jimmunol.167.5.2887","article-title":"Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4","volume":"167","author":"Smiley","year":"2001","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2018.e00508_bib0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1084\/jem.20001858","article-title":"Oligosaccharides of Hyaluronan activate dendritic cells via Toll-like receptor 4","volume":"195","author":"Termeer","year":"2002","journal-title":"J. Exp. Med."},{"issue":"49","key":"10.1016\/j.heliyon.2018.e00508_bib0120","doi-asserted-by":"crossref","first-page":"12826","DOI":"10.1523\/JNEUROSCI.4937-05.2006","article-title":"Toll-like receptor 2 signaling in response to brain injury: an innate bridge to neuroinflammation","volume":"26","author":"Babcock","year":"2006","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.heliyon.2018.e00508_bib0125","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1523\/JNEUROSCI.22-07-02478.2002","article-title":"The Toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS","volume":"22","author":"Lehnardt","year":"2002","journal-title":"J. Neurosci."},{"issue":"3","key":"10.1016\/j.heliyon.2018.e00508_bib0130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/8.3.397","article-title":"Intranuclear inclusions and neuritic aggregates in transgenic mice expressing a mutant N-terminal fragment of huntingtin","volume":"8","author":"Schilling","year":"1999","journal-title":"Hum. Mol. Genet."},{"issue":"3\u20134","key":"10.1016\/j.heliyon.2018.e00508_bib0135","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1242\/dmm.002451","article-title":"Mouse models of Huntington disease: variations on a theme","volume":"2","author":"Ehrnhoefer","year":"2009","journal-title":"Dis. Model Mech."},{"issue":"5","key":"10.1016\/j.heliyon.2018.e00508_bib0140","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.tins.2011.02.005","article-title":"Toll-like receptor signaling in neural plasticity and disease","volume":"34","author":"Okun","year":"2011","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.heliyon.2018.e00508_bib0145","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chom.2012.07.004","article-title":"Transient inability to manage proteobacteria promotes chronic gut inflammation in TLR5-deficient mice","volume":"12","author":"Carvalho","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"6","key":"10.1016\/j.heliyon.2018.e00508_bib0150","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.cmet.2015.09.028","article-title":"Microbiota-dependent hepatic lipogenesis mediated by stearoyl CoA desaturase 1 (SCD1) promotes metabolic syndrome in TLR5-deficient mice","volume":"22","author":"Singh","year":"2015","journal-title":"Cell Metab."},{"issue":"5975","key":"10.1016\/j.heliyon.2018.e00508_bib0155","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1126\/science.1179721","article-title":"Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5","volume":"328","author":"Vijay-Kumar","year":"2010","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.heliyon.2018.e00508_bib0160","first-page":"3909","article-title":"Deletion of TLR5 results in spontaneous colitis in mice","volume":"117","author":"Vijay-Kumar","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.heliyon.2018.e00508_bib0165","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbi.2013.10.013","article-title":"Toll-like receptors 2 and 4 modulate autonomic control of heart rate and energy metabolism","volume":"36","author":"Okun","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"35","key":"10.1016\/j.heliyon.2018.e00508_bib0170","doi-asserted-by":"crossref","first-page":"15625","DOI":"10.1073\/pnas.1005807107","article-title":"Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis","volume":"107","author":"Okun","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.heliyon.2018.e00508_bib0175","doi-asserted-by":"crossref","first-page":"e47522","DOI":"10.1371\/journal.pone.0047522","article-title":"Evidence for a developmental role for TLR4 in learning and memory","volume":"7","author":"Okun","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.heliyon.2018.e00508_bib0180","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/epi.13688","article-title":"Toll-like receptor 3 deficiency decreases epileptogenesis in a pilocarpine model of SE-induced epilepsy in mice","volume":"58","author":"Gross","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.heliyon.2018.e00508_bib0185","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12974-015-0310-z","article-title":"Absence of Toll-like receptor 4 (TLR4) extends survival in the hSOD1 G93A mouse model of amyotrophic lateral sclerosis","volume":"12","author":"Lee","year":"2015","journal-title":"J. Neuroinflamm."},{"issue":"15","key":"10.1016\/j.heliyon.2018.e00508_bib0190","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1093\/hmg\/ddn139","article-title":"Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus","volume":"17","author":"Warby","year":"2008","journal-title":"Hum. Mol. Genet."},{"issue":"52","key":"10.1016\/j.heliyon.2018.e00508_bib0195","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"14","key":"10.1016\/j.heliyon.2018.e00508_bib0200","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","article-title":"Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice","volume":"285","author":"Bradford","year":"2010","journal-title":"J. Biol. Chem."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844017320674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844017320674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T09:52:19Z","timestamp":1570614739000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844017320674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2405844017320674"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2018.e00508","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington\u2019s disease mice","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2018.e00508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e00508"}}